SOX2 and breast carcinoma: In breast cancer, SOX2 and MALAT1 expression were significantly elevated in ER/PR-negative and human epidermal growth factor receptor 2 (HER2)-positive cases, cancers that are associated with poor prognosis and high metastatic potential.